Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
-
Monthly Archives: January 2012
U.S. FDA approves new skin cancer medicine
The United States Food and Drug Administration (FDA) on Monday announced the approval of a drug to treat one of most common types of skin cancer. The FDA approved Erivedge (vismodegib), reviewed under the agency`s priority review program and ahead of the March 8 prescription user fee goal date, to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug, however, is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic) Continue reading
Posted in Cell Medicine
Tagged a-slow-growing, cell-carcinoma, death-or-severe, development, fda, hematology, locally-advanced, oncology, skin, ultraviolet, weight-loss
Comments Off
Harper Government invests in personalized medicine
Improving the quality of life of Canadians by developing more effective treatmentsOTTAWA , Jan. 31, 2012 /CNW/ – The Harper Government today announced an important investment that will help Canadians in … Continue reading
Posted in Cell Medicine
Tagged cnw, developing-more, effective-treatments, harper, harper-government, important-investment, improving-the-quality, quality, the-quality, today-announced
Comments Off
Scientists Transform Skin Cells Direct To Brain Cells, Bypassing Stem Cell Stage
Featured Article Academic Journal Main Category: Stem Cell Research Also Included In: Neurology / Neuroscience; Biology / Biochemistry Article Date: 31 Jan 2012 – 2:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient / Public: 5 (1 votes) Healthcare Prof: Bypassing the stem cell stage, researchers at the Stanford University School of Medicine in California converted mouse skin cells directly into neural precursor cells, the cells that go on to form the three main types of cell in the brain and nervous system. Continue reading
Posted in Cell Medicine
Tagged article, biology, health-, medical, national, neuroscience, privacy, research, study
Comments Off
FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma
Genentech, a member of the Roche Group , today announced that ErivedgeTM capsule was approved by the U.S. Continue reading
Posted in Cell Medicine
Tagged adults-with, after-surgery, called-basal, cell-carcinoma, erivedge, today-announced, treated-with, treatment
Comments Off
ATCC SDO Releases Ground-Breaking Standard for Human Cell Lines
MANASSAS, Va.–(BUSINESS WIRE)– The ATCC® Standards Development Organization (ATCC SDO), an entity of ATCC, has published its second voluntary consensus standard, ASN-0002: “Authentication of Human Cell Lines: Standardization of STR Profiling.” This consensus standard is expected to have broad impact across basic cell research, drug discovery, and translational medicine. Continue reading
Posted in Cell Medicine
Tagged a-developer-and, development, environment, human-cell, london-, organization, president, safety, standard, tools--, university
Comments Off
Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington …
Fibrocell Science, Inc. , a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announces that the June 2011 FDA approval of LAVIV™ for the improvement of the appearance of “smile line” wrinkles was named the #3 top story of 2011 in cell and gene therapy and regenerative medicine at The 2012 Cell & Gene Therapy Forum … Continue reading
Posted in Cell Therapy
Tagged development, improvement, june, medicine-at-the, named-the, smile-line, the-appearance, the-development, therapy, top-story
Comments Off
RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow …
SALT LAKE CITY, Jan. 31, 2012 /PRNewswire/ – RemedyMD, the leading provider of Translational Research Informatics, will launch Investigate™ Cell Therapy at the American Society for Blood and Marrow Transplantation … Continue reading
Posted in Cell Therapy
Tagged blood, city, informatics, leading, research-informatics, salt, the-leading, therapy, therapy-at-the, translational, will-launch
Comments Off
Stage-4 breast cancer survivor talks about stem cell treatment – Video
25-01-2012 18:06 A former stage-IV breast cancer patient talks about being treated at Stanford over a dozen years ago as part of a small clinical trial testing whether high-dose chemotherapy, followed by blood stem cell rescue with purified hematopoietic stem cells, could cure her cancer. Continue reading
Posted in Stem Cell Treatment
Tagged a-dozen-years, blood-stem, cell-rescue, dozen-years, high, patient-talks, treated-at-stanford, trial-testing
Comments Off
BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure
JUPITER, Fla., Jan. 31, 2012 /PRNewswire/ — BioRestorative Therapies, Inc. (OTCQB: BRTX) (“BRT”) today announced that it has entered into a License Agreement with Regenerative Sciences, LLC (“RS”) with respect to certain stem cell-related technology and clinical treatment procedures developed by RS. Continue reading
Posted in Stem Cell Treatment
Tagged a-brown-fat, fulfillment, fusions-or-back, license, once-it-begins, research, therapies--, weight-loss, well-as-further
Comments Off